Log in to save to my catalogue

Clinical management of patients with drug‐induced liver injury (DILI)

Clinical management of patients with drug‐induced liver injury (DILI)

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8435256

Clinical management of patients with drug‐induced liver injury (DILI)

About this item

Full title

Clinical management of patients with drug‐induced liver injury (DILI)

Author / Creator

Publisher

England: John Wiley & Sons, Inc

Journal title

United European Gastroenterology Journal, 2021-09, Vol.9 (7), p.781-786

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Drug‐induced liver injury (DILI) should be considered in all patients with recent elevation of liver tests without obvious etiology and normal hepatobiliary imaging. There is currently no biomarker that is helpful in diagnosis which relies on clinical and laboratory findings. Diagnosis is dependent on temporal relationship with a recently started d...

Alternative Titles

Full title

Clinical management of patients with drug‐induced liver injury (DILI)

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8435256

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8435256

Other Identifiers

ISSN

2050-6406

E-ISSN

2050-6414

DOI

10.1002/ueg2.12113

How to access this item